WinstonWınston
Hinge Health logo

Hinge Health

HNGE
45
Medical - Healthcare Information Services · Healthcare
Price
$87.09
+1.11 (+1.29%)
Market Cap
$6.74B
Winston Score
45
Winston is serious
Mixed quality — meaningful strengths and weaknesses.

Share count rising — dilution

+4.7% over 2y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 78.0M (2023) → 81.7M (2025)

Hinge Health is a digital health company that helps people manage chronic musculoskeletal pain — things like back pain, knee pain, and hip pain — without surgery or heavy medication. It sells its program to employers and health insurance plans, who then offer it as a benefit to their employees or members. The company operates mainly in the United States and is one of the larger digital physical therapy platforms in the country.

Hinge Health makes money by charging employers and insurers a per-member fee to access its app-based exercise therapy program, which includes wearable sensors and virtual coaching from physical therapists. Its 80% gross margin reflects the scalable, software-driven nature of the business, but the company is currently spending far more than it earns, resulting in deep operating losses. The key question going forward is whether Hinge Health can grow its customer base fast enough to reach profitability before it needs to raise more capital.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+47.2% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

-72.3% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$368M/ year

Rising (+265% vs prior year)

62.6% of revenue

3.5x the sector average (18%)

Investing heavily in future products and technology

Insider Activity

5.2%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$188M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

Hinge Health grew revenue 47% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
84.6%
Premium pricing power — 84.6% gross margin
Operating Margin
17.6%
Healthy — 17.6% operating margin
ROCE
10.2%
Below par — 10.2% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+49.8%
Fast-growing sales (49.8% YoY)
EPS YoY
-484.0%
Earnings shrinking (-484.0% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
31.9%
Converts sales into free cash efficiently (31.9%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.01
Conservative — low debt load (0.01)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial